According to Cognitive Market Research, the global Tumor Radiation Therapy Market size is USD 1056.25 million in 2024. It will expand at a compound annual growth rate (CAGR) of 5.50% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 422.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 316.88 million in 2024.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 242.94 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.
Latin America had a market share of around 5% of the global revenue with a market size of USD 52.81 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 21.13 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.
External Beam Radiation Therapy has the highest Tumor Radiation Therapy Market revenue share in 2024.
